Thanks Rudy...hey can you, or anyone else here, post the link to the scientific review article that discussed the advantages of the Cell-in-a-Box® encapsulation technology over alginate? I tried to find it but I keep getting a "bad gateway"...thanks in advance
With regards to JDRF having already funded the two other programs....is it possible they may very well regret not participating/funding the Ciab/MC combo for lack of involvement/support/belief if indeed PMCB gets FDA blessing?
Goldman said: "As a result, PharmaCyte Biotech's Cell-in-a-Box®-based treatment system approach could not only emerge as the superior encapsulation technique used to treat T1D, but it could attract the attention of the JDRF and other major diabetes research sponsors"
Isn't it too late for JDRF now that we are where we're at in this point and time?